Dosimetric guidance on using brachytherapy (LDR or HDR) to offset a flawed permanent prostate implant

被引:0
|
作者
Zaider, M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1118/1.2760839
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To provide practical dosimetric advice on mending suboptimal permanent implants using low dose‐rate (LDR) or high dose‐rate (HDR) brachytherapy (BRT). The problem is to make the combination of the two radiation treatments (the initial, flawed one and the compensatory boost) clinically isoeffective with the planned dose. Methods: The device of isoeffective dose (IED) is the appropriate tool for this purpose as it accounts for the physical (temporal distribution of dose) and biological (radiosensitivity, repair kinetics, proliferation rate) treatment setting. Results: I give, as a function of separation time from the initial, flawed treatment, and stratified by risk group representative values for the additional dose (LDR or HDR) needed to make the combined treatment isoeffective with a prescription of 144 Gy of permanently‐implanted [formula omitted] seeds. Conclusions: While the IED concept, within the constraints stated in the presentation, is rigorously valid, its practical implementation depends importantly on the relevant radiobiological parameters, and in this respect the reader is urged to use his own critical judgment. © 2007, American Association of Physicists in Medicine. All rights reserved.
引用
收藏
页码:2442 / 2442
页数:1
相关论文
共 50 条
  • [41] LDR brachytherapy offers superior tumor control to single-fraction HDR prostate brachytherapy: A prospective study
    Jimenez-Garcia, Isabel E.
    Sabater, Sebastia
    Martinez-Gutierrez, Rocio
    Sanchez-Galiano, Pedro
    Berenguer-Serrano, Roberto
    Castro-Larefors, Susana
    Rey-Lopez, Irene
    Ruiz-Herrero, Beatriz
    Sanchez-Prieto, Ricardo
    Rovirosa, Angeles
    Arenas, Meritxell
    Gonzalez-Suarez, Herminio A.
    PROSTATE, 2023, 83 (11): : 1068 - 1075
  • [42] The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis
    Nag, S
    Bice, W
    DeWyngaery, K
    Prestidge, B
    Stock, R
    Yu, Y
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (01): : 221 - 230
  • [43] Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry
    Nosrati, J. D.
    Sidiqi, B. U.
    Riegel, A. C.
    Cooney, A.
    To, S.
    Potters, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E235 - E236
  • [44] Dosimetric predictors of sexual function decline following LDR brachytherapy for prostate cancer (PCa).
    Mian, Omar Y.
    Robertson, Scott P.
    Narang, Amol
    Aggarwal, Sameer
    Bae, Hee Joon
    Gergis, Carol
    McNutt, Todd R.
    Tran, Phuoc T.
    DeWeese, Theodore L.
    Song, Danny
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [45] Dosimetric effects of different source arrangements in permanent prostate brachytherapy
    Herein, A.
    Agoston, P.
    Polgar, C.
    Major, T.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S328 - S329
  • [46] Improving Permanent LDR Partial Breast Brachytherapy with CBCT and Surface-Map Guidance
    Richardson, S.
    MEDICAL PHYSICS, 2017, 44 (06)
  • [47] Prostate brachytherapy (LDR) with 125I permanent implantation;: Experience at CROB
    Cocco, G.
    Iadanza, L.
    Zucca, S.
    Castaldo, G.
    Lapadula, L.
    Montagna, A.
    Mazziotta, M.
    Imbriani, E.
    Silvestre, G.
    Fusco, V.
    ANNALS OF ONCOLOGY, 2006, 17 : VII153 - VII153
  • [48] Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131CS and 125I for prostate permanent implant brachytherapy
    Sahgal, Arjun
    Jabbari, Siavash
    Chen, Josephine
    Pickett, Barbie
    Roach, Mack, III
    Weinberg, Vivian
    Hsu, I-Chow
    Pouliot, Jean
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : 247 - 254
  • [49] Dosimetry Evaluation of LDR Brachytherapy Treatment Planning for Prostate Seed Implant (PSI)
    Anton, A.
    Gordon, W.
    Zheng, Y.
    Ellis, R. J.
    Dill, S.
    Piper, J. W.
    Wessels, B. W.
    Colussi, V. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S407 - S407
  • [50] PSA outcomes after LDR/HDR brachytherapy in LR and IR prostate cancer: a predictor of response
    Rodriguez Villalba, Silvia
    Guevara Barrera, Diana
    Suso Marti, Luis
    Sanchis Sanchis, Enrique
    Perez-Calatayud, Jose
    Perez Calatayud, Maria Jose
    Santos Ortega, Manuel
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S400 - S401